>
A Nose For Attacking Cancern
Publication Date: February 5, 2025
Published By: The Bio Report Podcast
Article Link: https://open.spotify.com/episode/0raRIZm6OicjYXtrZSLdq9
NeOnc’s CEO and CSO Dr. Thomas Chen sat down for an interview on the Bio Report Podcast. The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
“One of the challenges in treating brain cancer and other diseases of the central nervous system is delivering therapeutics beyond the blood-brain barrier.” said host Daniel Levine, “NeOnc Technologies using a natural compound derived from essential oils in plants that not only can kill cancer cells, but can cross the blood-brain barrier. What’s more, it can transport other therapies as well. We spoke to Thomas Chen, founder and CEO of NeOnc, about brain cancer, how the blood-brain barrier complicates the delivery of therapies to treat the condition, and how its experimental candidate that is delivered intranasally works.”